Skip to content

Clinical trials

Terminated Huntington Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Huntington Disease Status: Terminated Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20122
20141
20152
20171
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital2
Children's Hospital of Philadelphia1
Johns Hopkins University1
New York Stem Cell Foundation Research Institute1
Omeros Corporation1
Pfizer1
Prilenia1
Supernus Pharmaceuticals, Inc.1
Wave Life Sciences USA, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Huntington Disease10
Parkinson Disease3
Neoplasms2
Acquired Immunodeficiency Syndrome1
Alzheimer Disease1
Anemia, Sickle Cell1
Autism Spectrum Disorder1
Brain Damage, Chronic1
Chorea1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.